# Is Ipamorelin FDA-Approved? Regulatory Status (Ipamorelin)

> Is ipamorelin FDA approved? No. Never approved anywhere, failed its one Phase 2 trial, dropped from the 503A compounding list in 2024, banned by WADA. The full record.

Short answer: no — never, anywhere. The long answer is the most useful thing on this site.

## The short version

People search "is ipamorelin fda approved" expecting a yes-or-no, so here it is: no. Not now, not ever, not anywhere — not by the FDA, the EMA, or any other regulator [13]. That's the headline, and the rest of this page is the receipts.

This matters because the supplement and clinic world works hard to imply otherwise. "Clinically studied," "pharmaceutical-grade," "physician-prescribed" — the language is built to sound like approval without claiming it. Here's the real status in plain words: ipamorelin is a **research chemical**. It's lab material sold for research use, not a finished, approved medicine. It was investigated for one condition, that study failed, and development stopped. In 2024 the FDA narrowed the legal path for pharmacies to compound it. And it's banned in sport. Anyone selling it as a treatment is selling past every one of those facts.

## Never approved — and why that's not just a delay

Plenty of useful compounds are "not yet approved" because they're mid-pipeline. Ipamorelin is not one of those. It has never been approved as a drug by any regulatory authority [13], and the reason is closer to failure than to incompleteness. Its only published Phase 2 trial — for postoperative ileus — missed its primary endpoint, and no further clinical development followed [3]. Novo Nordisk discovered it; the ileus program was later carried by Helsinn; the program ended after Phase 2. There are no completed Phase 3 trials and no approved indication [3]. So when you see "not FDA-approved" on a vendor page treated as a minor technicality, understand that it reflects a failed efficacy program, not a drug waiting in the queue.

## The 2024 PCAC and 503A change

The most important recent development is the one almost nobody mentions. Section 503A is the FDA framework that governs what compounding pharmacies can legally make from bulk drug substances. In 2024 the FDA **removed ipamorelin acetate from Category 2** of the interim 503A bulk-substances list — the nominator withdrew it in September 2024 — and reviewed both the acetate and the free base at the **October 29, 2024 Pharmacy Compounding Advisory Committee (PCAC) meeting** [13]. Ipamorelin is not an approved bulk substance for compounding. In practical terms: a route through which compounding pharmacies could supply ipamorelin got narrower, and the agency's posture tightened. If you've noticed clinics getting cagey about it lately, this is why.

## Banned in sport, at all times

For anyone who competes under anti-doping rules, the status is unambiguous. Ipamorelin and other growth hormone secretagogues are prohibited **at all times** under the World Anti-Doping Agency (WADA) Prohibited List, category S2 (peptide hormones, growth factors, related substances and mimetics) [14]. It's not a competition-only restriction, and accredited anti-doping laboratories have established urine methods to detect it [14]. A 2026 sports-medicine review puts ipamorelin squarely inside the expanding peptide-detection framework and flags serious safety concerns in uncontrolled use [15]. If you're a tested athlete, the regulatory answer here is simple: it's banned.

## What "research chemical" actually means

The phrase is doing a lot of quiet work on vendor sites, so let's define it. A **research chemical** is a substance sold for laboratory research — characterizing biology, running assays — explicitly not for human consumption or therapeutic use [13]. Research-grade material is not a drug product: it carries no pharmaceutical quality assurance, and from unregulated suppliers its purity, identity, and sterility are unverified [3]. Calling something research-grade is not a wink-and-nod synonym for "medicine you can use" — it's the opposite. The gap between "sold for research" and "approved for people" is the entire regulatory story of ipamorelin, and it's why this site, despite its name, points you at the literature instead of a checkout.

---

It says shop; it sells nothing — just a zine pinning ipamorelin's never-approved, pulled-from-the-503A-list, banned-in-sport record next to what the studies actually measured.